123 related articles for article (PubMed ID: 33712119)
1. Deciphering molecular mechanics in the taste masking ability of Maltodextrin: Developing pediatric formulation of Oseltamivir for viral pandemia.
Kalra A; Bhat P; Kaur IP
Carbohydr Polym; 2021 May; 260():117703. PubMed ID: 33712119
[TBL] [Abstract][Full Text] [Related]
2. Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets.
Tung NT; Tran CS; Nguyen TL; Hoang T; Trinh TD; Nguyen TN
Eur J Pharm Biopharm; 2018 May; 126():187-200. PubMed ID: 28359878
[TBL] [Abstract][Full Text] [Related]
3. Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures.
Wei Y; Nedley MP; Bhaduri SB; Bredzinski X; Boddu SH
AAPS PharmSciTech; 2015 Apr; 16(2):455-65. PubMed ID: 25361901
[TBL] [Abstract][Full Text] [Related]
4. Taste Masking of Griseofulvin and Caffeine Anhydrous Using Kleptose Linecaps DE17 by Hot Melt Extrusion.
Juluri A; Popescu C; Zhou L; Murthy RN; Gowda VK; Chetan Kumar P; Pimparade MB; Repka MA; Murthy SN
AAPS PharmSciTech; 2016 Feb; 17(1):99-105. PubMed ID: 26288942
[TBL] [Abstract][Full Text] [Related]
5. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
Rahman Z; Zidan AS; Berendt RT; Khan MA
Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate.
Shah PP; Mashru RC
AAPS PharmSciTech; 2008; 9(3):1025-30. PubMed ID: 18770047
[TBL] [Abstract][Full Text] [Related]
7. Oseltamivir phosphate-amberlite(TM) IRP 64 ionic complex for taste masking: preparation and chemometric evaluation.
Siddiqui A; Shah RB; Khan MA
J Pharm Sci; 2013 Jun; 102(6):1800-1812. PubMed ID: 23559456
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of taste masked ondansetron-magnesium aluminum silicate adsorption systems.
Kharb V; Saharan VA; Kharb V; Jadhav H; Purohit S
Drug Dev Ind Pharm; 2016 Aug; 42(8):1291-9. PubMed ID: 26641930
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
10. HME-assisted formulation of taste-masked dispersible tablets of cefpodoxime proxetil and roxithromycin.
Patil PS; Suryawanshi SJ; Patil SS; Pawar AP
J Taibah Univ Med Sci; 2024 Apr; 19(2):252-262. PubMed ID: 38616800
[TBL] [Abstract][Full Text] [Related]
11. A new strategy for taste masking of azithromycin antibiotic: development, characterization, and evaluation of azithromycin titanium nanohybrid for masking of bitter taste using physisorption and panel testing studies.
Amin F; Khan S; Shah SMH; Rahim H; Hussain Z; Sohail M; Ullah R; Alsaid MS; Shahat AA
Drug Des Devel Ther; 2018; 12():3855-3866. PubMed ID: 30510401
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.
Shah PP; Mashru RC
J Pharm Pharmacol; 2008 Oct; 60(10):1279-85. PubMed ID: 18812020
[TBL] [Abstract][Full Text] [Related]
14. Design, evaluation and optimization of taste masked clarithromycin powder.
Ntemi PV; Walker RB; Khamanga SMM
Pharmazie; 2019 Dec; 74(12):721-727. PubMed ID: 31907110
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.
Alshetaili AS; Almutairy BK; Tiwari RV; Morott JT; Alshehri SM; Feng X; Alsulays BB; Park JB; Zhang F; Repka MA
Curr Drug Deliv; 2016; 13(5):730-41. PubMed ID: 26456211
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous Silica Carrier-Based Composites for Taste-Masking of Bitter Drug: Fabrication and Palatability Evaluation.
Zhang W; Li G; Xiao C; Chang X; Sun Y; Fan W; Tian B; Gao D; Xiao Y; Wu X; He S; Zhai G
AAPS PharmSciTech; 2022 Feb; 23(2):75. PubMed ID: 35169970
[TBL] [Abstract][Full Text] [Related]
17. Novel risperidone orally disintegrating minitablets for pediatric use: patient acceptance and dose adjustment.
Bebawy G; Sokar M; Abdallaha OY
Drug Dev Ind Pharm; 2021 Apr; 47(4):542-551. PubMed ID: 33492181
[TBL] [Abstract][Full Text] [Related]
18. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.
Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
Pharm Dev Technol; 2015; 20(5):528-39. PubMed ID: 24490806
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste.
Omar SM; Ibrahim F; Ismail A
Saudi Pharm J; 2020 Mar; 28(3):349-361. PubMed ID: 32194337
[TBL] [Abstract][Full Text] [Related]
20. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
